Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2008
10/09/2008US20080248477 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
10/09/2008US20080248476 Using presence of single nucleotide polymorphism in fibronectin gene as evaluative indicator of heart disorders
10/09/2008US20080248475 Methods and Compositions for Modulating Gluconeogenesis Using PGC-1
10/09/2008US20080248465 Polymorphisms in the Fcgr2b Promoter and Uses Thereof
10/09/2008US20080248463 Split Enzyme Linked Immunosorbent and Nucleic Acid Assays
10/09/2008US20080248462 Using peptidase as evaluative tool in identifying modulators for prevention and treatment of cardiovascular, endocrinological, metabolic, cell proliferative, inflammatory, gastrointestinal, blood, respiratory, nervous system, urogenital and reproduction disorders
10/09/2008US20080248460 Composition and method for modulating an inflammatory response
10/09/2008US20080248172 substantiating fruit and/or vegetable servings and formulating based on nutritional guidelines for fruit and/or vegetables; based on nutrients, rather than based on volume
10/09/2008US20080248080 Decelluarlized Tissue Engineered Constructs and Tissues
10/09/2008US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use
10/09/2008US20080248054 Regulation of Mink in Thymocytes and T Lymphocytes
10/09/2008US20080248042 Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc
10/09/2008US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders
10/09/2008US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders
10/09/2008US20080248039 Antibodies Against Histone Modifications for Clinical Diagnosis and Prognosis of Cancer
10/09/2008US20080248034 Using lectin membrane protein specific immunoglobulin to treat, target and prevent cell proliferative disorders
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248026 PTEN/Akt methods and compositions relating to BMP
10/09/2008US20080248024 Using oligonucleotides specific to zinc finger protein 91 (ZFP91) as therapeutic inhibitors in treatment of cell proliferative, inflammatory and gastrointestinal disorders; RNA interference
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248011 Immunoglobulin for identifying cells expressing monocyte integral membrane proein (HIDE-1); inducing propagation of dendritic cell for use in treatment of autoimmune, tumor and organ rejection disorders
10/09/2008US20080248010 Protein kinase for use as tool in identifying modulators for treatment of diabetes
10/09/2008US20080248009 Using antisense agents specific to apoptosis-associated nucleic acids to modulate apoptosis in transplanted tissues; treating cell proliferative disorders
10/09/2008US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders
10/09/2008US20080248006 Propagating osteogenic or bone precursor cells in nutrient broth; tissue engineering and repair; regenerative medicine; treating and/or preventing bone disorders
10/09/2008US20080248000 CD14 and CD34 expressing adult stem cell culture for use in treatment of vascular disorders; tissue engineering and repair; regenerative medicine
10/09/2008US20080247999 Cyclin dependent kinase-4 (CDK-4) peptides for use in treatment of cell proliferative disorders; antitumor agents
10/09/2008US20080247990 Recombinant lymphocyte expressing CD16 receptor for use in targeting and destroying viral infection and tumor tissues
10/09/2008US20080247964 Substituted azaspiro derivatives
10/09/2008US20080247956 Identification of novel factors that block programmed cell death or apoptosis by targeting jnk
10/09/2008US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference
10/09/2008US20080247954 Especially oxazole, thiazole and imidazole compounds 2-substituted with phenyl -cycloalkyl or -bicycloalkyl groups; drug screening
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008US20080247911 Measurement of Concentrations and Binding Energetics
10/09/2008US20080247905 Microparticles with enhanced covalent binding capacity and their uses
10/09/2008US20080246946 Method and a system for determination of particles in a liquid sample
10/09/2008US20080246230 Seal for Measuring Device
10/09/2008US20080245665 Biosensor
10/09/2008US20080245135 Device: bonded wafers; a microfluidic channel within the bonded wafers; a nanoelectromechanical mass detector encapsulated within the microfluidic channel
10/09/2008US20080245134 Method of monitoring a surfactant in a microelectronic process by absorbance
10/09/2008US20080245132 Methods of detecting and eliminating tainted cork wine bottle stoppers
10/09/2008DE202008010270U1 Vorrichtung zur Durchführung des Härtetests von Prüflingen Apparatus for performing the hardness tests of specimens
10/09/2008DE202008003273U1 Testkit zum immunologischen Ermitteln des Progesterongehalts einer Probe und Vorrichtung hierfür Test kit for the immunological determination of the progesterone content of a sample and apparatus therefor
10/09/2008DE102008013776A1 Ethanolkompensierte Kraftstoffdichte zur Berechnung von verbrauchtem Kraftstoff Ethanol fuel density compensated for the calculation of fuel consumed
10/09/2008DE102007016699A1 Biochip für die Fluoreszenzanalyse von einzelnen Transportern Biochip for the fluorescence analysis of individual transporters
10/09/2008DE102007016612A1 Vorrichtung und Verfahren zur Untersuchung eines heterogenen Materials mittels laserinduzierter Plasmaspektroskopie Apparatus and method for investigation of a heterogeneous material by means of laser-induced plasma spectroscopy
10/09/2008DE102007016324A1 Verfahren zum Nachweis von pathologisch verändertem Prion-Protein (PrPSc) A method for detecting pathologically altered prion protein (PrPSc)
10/09/2008DE102007016301A1 Laser-Mikrodissektionsverfahren und Laser-Mikrodissektionsvorrichtung Laser microdissection and laser Mikrodissektionsvorrichtung
10/09/2008DE102007015886A1 TIMP-4 als Biomarker zur Diagnose einer Herzinsuffizienz TIMP-4 as a biomarker for the diagnosis of heart failure
10/09/2008DE102007015775A1 Verfahren zum Nachweis von Paratuberkolose A method for detecting Paratuberkolose
10/09/2008DE102007015543A1 Method for detection of biological reaction products on sensor surfaces, involves moving beads into desired direction, particularly from berth to detected biologically active substances, where biological reaction products have Biotins
10/09/2008CA2683370A1 Cross-species-specific binding domain
10/09/2008CA2682575A1 Diagnostic assay
10/09/2008CA2682513A1 Stabilized gold nanoparticles and methods of making and using the same
10/09/2008CA2682325A1 Inverse agonist effect from the cocaine binding site
10/09/2008CA2682155A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
10/09/2008CA2682132A1 Use of he4 for assessment of breast cancers
10/09/2008CA2682114A1 Method of determining risk of scoliosis
10/09/2008CA2682100A1 Transgenic animal models of disease
10/09/2008CA2682093A1 Antibodies, methods and kits for diagnosing and treating melanoma
10/09/2008CA2680701A1 Methods and compositions for modulating il-17f/il-17a biological activity
10/09/2008CA2680064A1 Calibration and normalization method for biosensors
10/09/2008CA2672408A1 Pharmaceutical platform technology for the development of natural products
10/08/2008EP1978366A1 Fluorescent label for biomaterial and method of fluorescent-labeling biomaterial
10/08/2008EP1978365A1 Reagent kit and method for measuring HCV antibody
10/08/2008EP1978364A1 Transglutaminase 6 as a diagnostic indicator of autoimmune diseases
10/08/2008EP1978363A1 Immunoassay method, reagent kit for detecting alkaline phosphatase, and reagent kit for immunoassay
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978361A2 Method for performing correction of blood glucose assay bias using blood hemoglobin concentration as determined by a glucose-hemoglobin A1C combination system and devices for same
10/08/2008EP1978360A1 A method to improve barrier function of cell-cell junctions
10/08/2008EP1978359A1 Methods for predicting warp at a given condition
10/08/2008EP1978358A2 Sensor for detecting a toxic or hazardous gas mixture and operating method
10/08/2008EP1978356A1 Method for managing the successive in-line analysis of a series of liquid samples brought to boiling point in an analysis flask
10/08/2008EP1978352A1 Method for calculating the concentration of cleaning and/or disinfection and/or additive material dissolved in a fluid
10/08/2008EP1978350A2 Method for measuring surface plasmon resonance
10/08/2008EP1978346A1 Method for checking surface condition after cleaning process
10/08/2008EP1978303A2 A method of firebox temperature control for achieving carbon monoxide emission compliance in industrial furnaces with minimal energy consumption
10/08/2008EP1978110A1 System, method and apparatus for transgenic and targeted mutagenesis screening
10/08/2008EP1978108A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978093A1 Method of crosslinking two objects of interest
10/08/2008EP1978035A1 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/08/2008EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
10/08/2008EP1978033A2 Human antibodies derived from immunized xenomice
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1977755A1 Shrimp allergen antishrimp allergen antibody and use thereof
10/08/2008EP1977444A2 Sensing devices from molecular electronic devices
10/08/2008EP1977254A2 Systems and methods involving data patterns such as spectral biomarkers
10/08/2008EP1977253A2 Homocysteine immunoassay
10/08/2008EP1977252A1 Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
10/08/2008EP1977251A1 Antibody characterization test
10/08/2008EP1977250A1 Method and markers for the diagnosis of renal diseases
10/08/2008EP1977249A2 Method of diagnosis and method of treatment
10/08/2008EP1977248A2 Human zip1, zinc and citrate for prostate cancer screening
10/08/2008EP1977247A2 Methods for diagnosing and treating prostate cancer
10/08/2008EP1977246A1 Na+, k+-atpase expression in cervical dysplasia and cancer
10/08/2008EP1977245A1 Method for determining the concentration of virus particles/virus antigens
10/08/2008EP1977244A1 Distinction between bacterial meningitis and viral meningitis
10/08/2008EP1977243A2 High optical purity copolymer film
10/08/2008EP1977242A2 Lateral flow immunoassay with encapsulated detection modality
1 ... 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 ... 3937